Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Home > ½ÃÀ庸°í¼­ > ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö > Ç×ü/¸é¿ª > Áß±¹ÀÇ ¼¼ÆÈ·Î½ºÆ÷¸° ½ÃÀå
Ä«Å×°í¸®
¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö (1470)
°Ô³ð â¾à (202)
¸ÂÃãÇüÀÇ·á (54)
¹ÙÀÌ¿À¸¶Ä¿ (154)
¹ÙÀÌ¿À¸ÅÆ®¸®¾ó (55)
¹ÙÀÌ¿ÀÀåºñ (323)
ºÐÀÚÇ¥ÀûÄ¡·á(MTT) (53)
À¯ÀüÀÚ Ä¡·á/RNAi (100)
Àç»ýÀÇÇÐ (125)
Ç×ü/¸é¿ª (188)
½ÃÀ庸°í¼­

Áß±¹ÀÇ ¼¼ÆÈ·Î½ºÆ÷¸° ½ÃÀå

Chinese Markets for Cephalosporins

¸®¼­Ä¡»ç Asia Market Information & Development
¹ßÇàÀÏ 2008³â 06¿ù »óǰÄÚµå 66901
ÆäÀÌÁö Á¤º¸ 239 Pages
°¡°Ý
US $ 4,000 £Ü 4,542,000 PDF by E-mail (Single User License)
US $ 7,000 £Ü 7,948,500 PDF by E-mail (Corporate Use License)


Asia Market Information & Development ¿¡¼­ 2008³â 06¿ù ¿¡ ¹ßÇàÇÑ ¡¸Áß±¹ÀÇ ¼¼ÆÈ·Î½ºÆ÷¸° ½ÃÀ塹 º¸°í¼­´Â 239 Pages·Î ±¸¼ºµÇ¾î, US $4,000 ºÎÅÍ ±¸¸Å °¡´ÉÇÕ´Ï´Ù.

Çѱ۸ñÂ÷

Áß±¹ ¼¼ÆÈ·Î½ºÆ÷¸° ½ÃÀåÀÇ ¼ö¿ä´Â °ú°Å 10³â°£ ±Þ¼ÓÈ÷ ¼ºÀåÇÏ¿´½À´Ï´Ù. °è¼ÓÇØ¼­ ¾ÕÀ¸·Î 5³â°£µµ »ý»ê, ¼ö¿ä´Â ¼øÁ¶·Ó°Ô »ó½ÂÇØ °¥ °ÍÀÔ´Ï´Ù.

Áß±¹ÀÇ °æÁ¦ µ¿Çâ, ÅõÀÚ È¯°æ, »ê¾÷ÀÇ ¹ßÀü, ¼ö¿ä¿Í °ø±Þ, »ê¾÷ ±¸Á¶, ½ÃÀå °æ·Î ¹× ÁÖ¿ä ±â¾÷ µî¿¡ ´ëÇØ »ó¼¼È÷ Á¶»ç ºÐ¼®Çϰí 1997, 2002, 2007³âÀÇ ½ÇÀû ¹× 2012³â°ú 2017³âÀÇ Àå±â ¿¹ÃøÀ» Á¦½ÃÇØµå¸³´Ï´Ù.

    Á¦1Àå ¼­·Ð
    • º» º¸°í¼­ÀÇ ¹üÀ§ ¹× ¹æ¹ý·Ð
    • °³¿ä
    Á¦2Àå ºñÁî´Ï½º ȯ°æ
    • °æÁ¦ Àü¸Á
      • ÁÖ¿ä °æÁ¦ ÁöÇ¥
      • °ø¾÷ »ý»ê°í
      • Àα¸ ¹× ³ëµ¿·Â
      • ÇØ¿Ü·ÎºÎÅÍÀÇ ÅõÀÚ
      • ÇØ¿Ü ¹«¿ª
    • ±ÝÀ¶ ¹× ¼¼±Ý ±ÔÁ¦¹ý
      • ÀºÇà Á¦µµ ¹× ±ÔÁ¦¹ý
      • ¿Üȯ
      • ¼¼±Ý, °ü¼¼ ¹× ¼¼°ü
    Á¦3Àå ¼¼ÆÈ·Î½ºÆ÷¸° »ê¾÷ Æò°¡
    • »ê¾÷ ±¸Á¶
    • ½ÃÀå ±Ô¸ð
    • »ê¾÷ ¿ë·®
    • ÁÖ¿ä Á¦Á¶»ç ¼³ºñ
    • ÁÖ¿ä »ý»ê½Ã¼³ Àå¼Ò
    • ÁÖ¿ä Á¦Á¶»ç
    • ³ëµ¿ ºñ¿ë
    • ÀáÀ缺ÀÖ´Â Âü°¡ ±â¾÷
    • ÁÖ¿ä ½Ç ¼ö¿äÀÚ
    • ÁÖ¿ä ÇØ¿Ü ÅõÀÚ
    • ±â¼ú °³¹ß
    • »ê¾÷ µ¿Çâ
    Á¦4Àå ¼¼ÆÈ·Î½ºÆ÷¸° »ý»ê ¹× ¼ö¿ä
    • °³¿ä
    • Á¦1¼¼´ë ¼¼ÆÈ·Î½ºÆ÷¸°
      • °³¿ä
      • ¼¼ÆÈ·º½Å(cephalexin)
      • ¼¼ÇÁ¶óµò(Cefradine)
      • ¼¼ÆÄÁ¹¸°(Cefazolin)
      • ¼¼ÆÄµå·Ï½Ç(Cefadroxil)
      • Cefathiamidine
      • ¼¼ÇÁÅ×Á¹(Ceftezole)
    • Á¦2¼¼´ë ¼¼ÆÈ·Î½ºÆ÷¸°
      • °³¿ä
      • ¼¼ÆÄŬ·¯(Cefaclor)
      • ¼¼ÇÁ·Ï½É(Cefuroxime, »ê³ªÆ®·ý/¿¡½ºÅ׸£)
    • Á¦3¼¼´ë ¼¼ÆÈ·Î½ºÆ÷¸°
      • °³¿ä
      • ¼¼ÇÁÆ®¸®¾Æ¼Õ(ceftriaxone)
      • ¼¼Æ÷Æä¶óÁ¸(cefoperazone) »ê³ªÆ®·ý
      • ¼¼Æ÷Æä¶óÁ¸ »ê³ªÆ®·ý°ú ¼³¹ÚŽ(Sulbactam) »ê³ªÆ®·ý
      • ¼¼Æ÷ŸÁü(Cefotaxime)
      • ¼¼ÇÁŸÁöµõ(Ceftazidime)
      • ¼¼ÇÁƼÁ·½É(Ceftizoxime)
      • ¼¼ÇȽÉ(Cefixime)
      • ¼¼Æ÷µðÁü(Cefodizime)
      • ¼¼ÆäŸ¸ä ÇǺ¹½Ç(Cefetamet Pivoxil)
      • ¼¼ÇÁµð´Ò(Cefdinir)
    • Á¦4¼¼´ë ¼¼ÆÈ·Î½ºÆ÷¸°
      • °³¿ä
    Á¦5Àå ¼¼ÆÈ·Î½ºÆ÷¸° ½ÃÀå Àü¸Á
    • ¼¼ÆÈ·Î½ºÆ÷¸° ½ÃÀå Àü¸Á
    • Á¦1¼¼´ë ¼¼ÆÈ·Î½ºÆ÷¸°
      • °³¿ä
      • ¼¼ÆÈ·º½Å
      • ¼¼ÇÁ¶óµò
      • ¼¼ÆÄÁ¹¸°
      • ¼¼ÆÄµå·Ï½Ç
      • Cefathiamidine
      • ¼¼ÇÁÅ×Á¹
    • Á¦2¼¼´ë ¼¼ÆÈ·Î½ºÆ÷¸°
      • °³¿ä
      • ¼¼ÆÄŬ·¯
      • ¼¼ÇÁ·Ï½É(»ê³ªÆ®·ý/¿¡½ºÅ׸£)
    • Á¦3¼¼´ë ¼¼ÆÈ·Î½ºÆ÷¸°
      • °³¿ä
      • ¼¼ÇÁÆ®¸®¾Æ¼Õ
      • ¼¼Æ÷Æä¶óÁ¸ »ê³ªÆ®·ý
      • ¼¼Æ÷Æä¶óÁ¸ »ê³ªÆ®·ý°ú ¼³¹ÚŽ »ê³ªÆ®·ý
      • ¼¼Æ÷ŸÁü
      • ¼¼ÇÁŸÁöµõ
      • ¼¼ÇÁƼÁ·½É
      • ¼¼ÇȽÉ
      • ¼¼Æ÷µðÁü
      • ¼¼ÆäŸ¸ä ÇǺ¹½Ç
      • ¼¼ÇÁµð´Ò
    • Á¦4¼¼´ë ¼¼ÆÈ·Î½ºÆ÷¸°
      • °³¿ä
    Á¦6Àå ½ÃÀå Âü°¡ °æ·Î
    • Áß±¹ ½ÃÀå Âü°¡ °³¿ä
    • Áß±¹ ½ÃÀåÀÇ Âü°¡
    Á¦7Àå ¼¼ÆÈ·Î½ºÆ÷¸° Á¦Á¶»ç ¼º¸í·Ï
    • Á¦Á¶»ç ÇÁ·ÎÆÄÀÏ ¹× ¼º¸í·Ï
    µµÇ¥ ¸®½ºÆ®
pmh
Back to Top